EIF4G2 and pancreatic neoplasm: It was found that MYEOV, GPRC5A, SERPINB5, KRAS, EGFR, and EIF4G2 were all significantly elevated in pancreatic cancer tissues, and the expression trends of GPRC5A, SERPINB5, KRAS, EGFR, and EIF4G2 in different stages were nearly identical (Figure 5A).